Recombinant ADAMTS-13 (Guangzhou Institutes of Biomedicine and Health)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant ADAMTS-13 (Guangzhou Institutes of Biomedicine and Health)
Drug Alias NamerhTS-13 (Guangzhou Institutes of Biomedicine and Health)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionA disintegrin and metalloproteinase with thrombospondin motifs 13 replacementVon willebrand factor inhibitors
TargetsA disintegrin and metalloproteinase with thrombospondin motifs 13Von willebrand factor
Therapy Area/IndicationsPurpura, ThrombocytopenicThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences
Active IndicationsN/A
Inactive IndicationsPurpura, ThrombocytopenicThrombosis

Other Information

ATC CodeN/A
Related LinksN/A